Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Nuclear Medicine and Biology|September 28, 2010
Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomasYukinari Kato, Ganesan Vaidyanathan, Mika Kato Kaneko, et al.
Current Radiopharmaceuticals|August 26, 2011
Synthesis and preliminary evaluation of n.c.a. iodoquine: a novel radiotracer with high uptake in cells with high ALDH1 expressionBennett B Chin, Anita Hjelemand, Jeremy Rich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2022
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for NeuroblastomaVandana Batra, Minu Samanta, Mehran Makvandi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2021
An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-TherapyRonnie C Mease, Choong Mo Kang, Vivek Kumar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical TherapyAna P Kiess, Il Minn, Ganesan Vaidyanathan, et al.
Chemistry & Biology|September 17, 2013
Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cellsJared J Barrott, Philip F Hughes, Takuya Osada, et al.
Nanotechnology|March 12, 2019
Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobeYang Liu, Austin B Carpenter, Christopher J Pirozzi, et al.
Pageof 9